https://www.chinahealthreport.com/article/915446238-asymbio-showcases-comprehensive-conjugation-toolbox-to-support-process-development-for-next-generation-bioconjugates China Health Report en PressRelease 2026-05-27T13:00:00+00:00 AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates https://ml.globenewswire.com/media/1d67b343-a22b-464b-978b-2ce7a34d4967/small/20260113-logo-for-enewsletter-jpg.jpg https://www.chinahealthreport.com/article/915421223-world-s-first-class-iii-approval-for-a-breakthrough-medical-imaging-ai-diagens-ai-autovision China Health Report en PressRelease 2026-05-27T10:49:09+00:00 World’s First Class III Approval for a Breakthrough Medical Imaging AI: Diagens AI AutoVision® https://ml.globenewswire.com/media/97921037-563c-4fca-95a3-bbcc69b4d2b1/medium/hangzhou-diagens-biotechnology.jpg https://www.chinahealthreport.com/article/915407513-innocare-announces-approval-of-orelabrutinib-in-australia China Health Report en PressRelease 2026-05-27T10:02:38+00:00 InnoCare Announces Approval of Orelabrutinib in Australia https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://www.chinahealthreport.com/article/915212085-choroideremia-research-foundation-announces-june-30-research-grant-application-deadline China Health Report en PressRelease 2026-05-26T18:14:44+00:00 Choroideremia Research Foundation Announces June 30 Research Grant Application Deadline https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24867463-june-30-grant-1280x720.png https://www.chinahealthreport.com/article/915312863-junshi-biosciences-announces-primary-endpoints-met-in-final-analysis-of-phase-3-study-for-perioperative-toripalimab-plus-chemotherapy-for-resectable China Health Report en PressRelease 2026-05-27T01:18:39+00:00 Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC https://ml.globenewswire.com/media/815f9c91-bb76-4c14-b3e9-0685275600cc/small/junshi-topalliance-logo-png.png https://www.chinahealthreport.com/article/914674265-magventure-receives-fda-clearance-for-accelerated-tms-protocols-expanding-flexibility-for-clinics-and-patients China Health Report en PressRelease 2026-05-26T12:00:00+00:00 MagVenture Receives FDA Clearance for Accelerated TMS Protocols, Expanding Flexibility for Clinics and Patients https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24857447-magventure-accelerated-tms-4096x4096.png